Table 2. Incidence rate changes in prostate cancer treatment modality for non-metastatic disease stratified by NICE risk group between 2000–2005 and 2006–201.
Treatment | Percentage 2000–2005 | Percentage 2006–2010 | SE | Z | p-value | Trend | |
---|---|---|---|---|---|---|---|
low risk | Conservative management | 35% | 66% | 0.0255 | -12.048 | 0.000 | Increase |
Radical prostatectomy | 22% | 13% | 0.0192 | 4.720 | 0.000 | Decrease | |
Radical radiotherapy | 30% | 16% | 0.0212 | 6.819 | 0.000 | Decrease | |
PADT | 13% | 6% | 0.0149 | 4.830 | 0.000 | Decrease | |
Intermediate risk | Conservative management | 21% | 29% | 0.0150 | -5.110 | 0.000 | Increase |
Radical prostatectomy | 14% | 19% | 0.0128 | -3.979 | 0.000 | Increase | |
Radical radiotherapy | 36% | 35% | 0.0163 | 0.718 | 0.473 | No change | |
PADT | 29% | 18% | 0.0141 | 8.192 | 0.000 | Decrease | |
High risk | Conservative management | 3% | 7% | 0.0062 | -6.386 | 0.000 | Increase |
Radical prostatectomy | 8% | 13% | 0.0088 | -6.019 | 0.000 | Increase | |
Radical radiotherapy | 30% | 34% | 0.0133 | -3.194 | 0.001 | Increase | |
PADT | 59% | 46% | 0.0141 | 9.530 | 0.000 | Decrease |